Identification of a Novel Ferroptosis-Related Gene Signature for Prediction of Prognosis in Bladder Urothelial Carcinoma [0.03%]
一种新的铁死亡相关基因签名用于预测膀胱尿路上皮癌预后
Xiaokai Shi,Xiao Zhou,Lei Zhang et al.
Xiaokai Shi et al.
Background: sBladder urothelial carcinoma is the most prevalent type of bladder cancer, characterized by drug resistance, high recurrence rate, and unfavorable prognosis. Ferroptosis is a newly discovered type of non-apop...
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab [0.03%]
阿特珠单抗治疗晚期尿路上皮癌患者生存情况与患者报告结果之间的相关性分析
Eugene Tan,Ahmad Y Abuhelwa,Sarah Badaoui et al.
Eugene Tan et al.
Background: Atezolizumab is an immune checkpoint inhibitor (ICI) and a frontline treatment of patients with cisplatin-ineligible advanced urothelial carcinoma (UC). There is limited evidence on the prognostic value of pat...
Angela B Smith,Sean McCabe,Allison M Deal et al.
Angela B Smith et al.
Background: Bladder cancer treatments may variably impact health-related quality of life (QOL). Objective: To characterize the quality ...
Piyush K Agarwal,Cora N Sternberg
Piyush K Agarwal
Accuracy of Inchworm Sign on Diffusion-Weighted MRI in Differentiating Muscle-Invasive Bladder Cancer [0.03%]
DWI序列inchworm征在肌层浸润性膀胱癌中的诊断价值
Huseyin Ozgur Kazan,Meftun Culpan,Nesrin Gunduz et al.
Huseyin Ozgur Kazan et al.
Background: Inchworm sign is a finding on diffusion-weighted magnetic resonance imaging (DWI-MRI) and is used to better stratify T-staging in muscle invasive (MIBC) and non-muscle-invasive bladder cancer (NMIBC). An unint...
Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer [0.03%]
肌 invasive 膀胱癌患者新辅助化疗中顺铂系统性回顾和荟萃分析
Raed Benkhadra,Tarek Nayfeh,Sai Krishna Patibandla et al.
Raed Benkhadra et al.
Background: Cisplatin-based neoadjuvant chemotherapy is the standard of care for muscle invasive bladder cancer (MIBC). Objective: To c...
Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple? [0.03%]
敏感性和特异性在尿路上皮肿瘤标志物中的评价简单吗？
Florian Roghmann,Peter J Goebell,Lars Dyrskjøt et al.
Florian Roghmann et al.
Marker research, and in particular urine bladder cancer marker research throughout the past three decades, devours enormous scientific resources in terms of manpower (not to mention time spent on reviewing and editorial efforts) and financi...
Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [0.03%]
局部晚期或转移性尿路上皮癌患者疼痛的定性分析
Susan Martin,Sonali N Shah,Zsolt Hepp et al.
Susan Martin et al.
Background: Pain is not well described in patients with locally advanced or metastatic urothelial cancer (la/mUC). Objective: To charac...
Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer [0.03%]
前瞻性评估FDG-PET/CT在侵袭性膀胱癌新辅助或诱导化疗疗效评价中的价值
Sarah M H Einerhand,Charlotte S Voskuilen,Elies E Fransen van de Putte et al.
Sarah M H Einerhand et al.
Background: Neoadjuvant/induction chemotherapy (NAIC) improves survival in patients with muscle-invasive bladder carcinoma (MIBC). On-treatment response assessment may aid in decisions to continue or cease NAIC. ...